HMB-45 IHC Test for Melanoma | Lahalak Medical Platform
A specialized immunohistochemical test for detecting pigmented cell tumors. It accurately differentiates between benign moles and malignant melanoma, ensuring the right treatment plan is initiated at an early stage.
Scientific name: Immunohistochemistry: HMB-45
An immunohistochemical (IHC) diagnostic package designed to detect tumors derived from melanocytes (pigment cells). The package focuses primarily on measuring the expression of HMB-45, an antibody that recognizes the gp100 antigen found in pre-melanosomal granules, making it a highly sensitive and specific marker for active melanocytes (especially...
Included Services
- Examination of HMB-45 expression, a high-quality marker of active melanocytes.
- Examination of S-100 expression, a highly sensitive marker of melanocytes and neurons.
- Melan-A (MART-1) expression test, a qualitative marker of mature melanocytes.
- Consult a dermatologist or general pathologist to interpret the overall results.
- Personal support services from Halak.
Medical Service Information
Conditions & Notices
- It requires the presentation of a tissue block (paraffin block) or microscopic slides from a biopsy of the suspected lesion.
- It is important to include a description of the pest (its location, color, size) if possible.
- There is no need to fast, as it is a test on a tissue sample.
- Expected duration: 5 to 10 working days.